Chronic hyperkalemia (HK) is a serious medical condition that often manifests in patients with chronic kidney disease (CKD) and heart failure (HF) leading to poor outcomes and necessitating careful management by cardionephrologists. CKD, HF, diabetes, and renin-angiotensin-aldosterone system inhibitors use is known to induce HK. Current therapeutic options are not optimal, as pointed out by a large number of CKD and HF patients with HK. The following review will focus on the main risk factors for developing HK and also aims to provide a guide for a correct diagnosis and present new approaches to therapy.
|Titolo:||Chronic Hyperkalemia in Cardiorenal Patients : Risk Factors, Diagnosis, and New Treatment Options|
|Parole Chiave:||Hyperkalemia; Chronic kidney disease; Heart failure; Renin-angiotensin-aldosterone system inhibitors; Potassium binder|
|Settore Scientifico Disciplinare:||Settore MED/14 - Nefrologia|
|Data di pubblicazione:||gen-2019|
|Data ahead of print / Data di stampa:||25-ott-2018|
|Digital Object Identifier (DOI):||10.1159/000493395|
|Appare nelle tipologie:||01 - Articolo su periodico|